Hiroaki Ogata

Has grant

Prof

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Hiroaki Ogata is a faculty member at Showa Daigaku Yokohama-shi Hokubu Byoin, Japan. His research focuses on cardiovascular events in patients undergoing hemodialysis, particularly the effects of phosphate and various pharmacological interventions. He has contributed significantly to understanding the implications of serum phosphate levels and medication use among chronic kidney disease patients, as evidenced by his recent publications.

Recent Grants

Grant: Close

Elucidation of Regulatory Mechanism of Vitamin D- Vitamin D Receptor System in Cardiovascular Tissues in Uremic Milieu

Open Date: 2020-04-01

Close Date: 2024-03-31

Grant: Close

尿毒症環境下の心血管組織におけるVD-VDR活性化調節機構の解明

Open Date: 2020-04-01

Close Date: 2024-03-31

Grant: Close

Vascular health and vitamin D under uremic condition

Open Date: 2018-04-01

Close Date: 2021-03-31

Grant: Close

Establishment of Pathological Model of Skeletal resistance to PTH in Uremia using iPS Cells

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

Ca Load Induces Vascular Smooth Muscle Cell Mineralization Partly Mediated by TRPV

Open Date: 2013-04-01

Close Date: 2016-03-31

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Fujioka Tatsuya

Associate Professor

Kansai Medical University

JAPAN

View details

Fumiyuki Hattori

Professor

Kansai Medical University

JAPAN

View details

takuya mizukami

Showa University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroaki Ogata

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

Association of serum phosphate levels and statin use with cardiovascular events in Japanese patients on chronic haemodialysis: a post-hoc analysis of the LANDMARK trial

Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis

Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial

Effect of renin–angiotensin system inhibitors on cardiovascular events in hemodialysis patients with hyperphosphatemia: A post hoc analysis of the LANDMARK trial

The induction of parathyroid cell differentiation from human induced pluripotent stem cells promoted via TGF-α/EGFR signaling.

Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis—A post hoc analysis of the LANDMARK study

Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease

Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial

An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles

Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients

Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial

Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.

Osteoblastic differentiation of bone marrow mesenchymal stem cells in uremic rats

Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats

Collaborators (3)

Fujioka Tatsuya

Fumiyuki Hattori

takuya mizukami

Make your next move.